Bill Text: NH SB688 | 2020 | Regular Session | Amended
Bill Title: Relative to the pricing of generic prescription drugs.
Spectrum: Moderate Partisan Bill (Democrat 5-1)
Status: (Engrossed - Dead) 2020-09-23 - Died on Table [SB688 Detail]
Download: New_Hampshire-2020-SB688-Amended.html
SB 688-FN - AS AMENDED BY THE SENATE
03/11/2020 1065s
2020 SESSION
20-2728
01/10
SENATE BILL 688-FN
AN ACT relative to the pricing of generic prescription drugs.
SPONSORS: Sen. Fuller Clark, Dist 21; Sen. Rosenwald, Dist 13; Sen. Hennessey, Dist 5; Sen. Sherman, Dist 24; Rep. McMahon, Rock. 7; Rep. Bartlett, Merr. 19
COMMITTEE: Commerce
-----------------------------------------------------------------
AMENDED ANALYSIS
This bill clarifies the pricing of generic prescription drugs under the law governing consumer protection.
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Explanation: Matter added to current law appears in bold italics.
Matter removed from current law appears [in brackets and struckthrough.]
Matter which is either (a) all new or (b) repealed and reenacted appears in regular type.
03/11/2020 1065s 20-2728
01/10
STATE OF NEW HAMPSHIRE
In the Year of Our Lord Two Thousand Twenty
AN ACT relative to the pricing of generic prescription drugs.
Be it Enacted by the Senate and House of Representatives in General Court convened:
1 Consumer Protection: Acts Unlawful. Amend RSA 358-A:2, XIV to read as follows:
XIV. Pricing of goods or services in a manner that tends to create or maintain a monopoly, or otherwise harm competition, including the pricing of generic prescription drugs.
2 Effective Date. This act shall take effect upon its passage.
20-2728
1/7/20
SB 688-FN- FISCAL NOTE
AS INTRODUCED
AN ACT prohibiting price gouging in the sale of prescription drugs.
FISCAL IMPACT: [ X ] State [ ] County [ ] Local [ ] None
|
| |||
| Estimated Increase / (Decrease) | |||
STATE: | FY 2020 | FY 2021 | FY 2022 | FY 2023 |
Appropriation | $0 | $0 | $0 | $0 |
Revenue | $0 | $0 | $0 | $0 |
Expenditures | $0 | Indeterminable Increase | Indeterminable Increase | Indeterminable Increase |
Funding Source: | [ X ] General [ ] Education [ ] Highway [ ] Other |
The Judicial Branch was originally contacted for a fiscal note worksheet on November 18, 2019, which they have not provided as of January 7, 2020.
METHODOLOGY:
This bill requires the commissioner of the Department of Health and Human Services to notify the Department of Justice of certain price increases for essential off-patent or generic drugs. The bill authorizes the Department of Justice to issue a civil investigative demand upon receipt of notification of suspected price gouging or in any other case in which the Department has reasonable cause to believe that unfair price gouging has occurred or is about to occur. The Department of Justice expects the bill to result in an increased number of investigations, with an indeterminable fiscal impact. The Department of Health and Human Services likewise expects an indeterminable cost associated with monitoring and reporting on price increases.
AGENCIES CONTACTED:
Department of Health and Human Services, Department of Justice, and Judicial Branch